Quetiapine Fumarate XR Tablets
Dept of Defense · DEFENSE LOGISTICS AGENCY
This notice is not accepting responses.
Page kept for research and related open opportunities below. For current work in this category, use the related notices or browse hubs.
- Response deadline
- Not listed
- Posted
- Sep 18, 2023
- Solicitation
- SPE2D223D0012
- Set-aside
- None listed
- Place of performance
- Hauppauge, NY, USA
- Contracting office
- DLA TROOP SUPPORT · PHILADELPHIA · PA
- Source
- SAM.gov · updated May 9, 2026
Description
Modification SPE2D223D0012 P00001 to change the price effective date from December 17, 2023 to October 18, 2023. Modification SPE2D223D0012 P00001 to incorporate Drug Supply Chain Security Act language into solicitation for subject contract. Award SPE2D223D0012 Quetiapine Fumarate XR Tablets
What similar awards have paid
Real federal awards already on the books in a similar lane — so you can size the opportunity, not guess. This is public history, not a bid price, cost estimate, or prediction that you will win.
Typical award size
$36,321
Middle of the pack for similar past awards
Most similar awards fall between $8,499 and $203,138
Who has won work like this
Public awardees in this lane — useful for competitor scan or teaming ideas, not a ranked list of “best” firms.
- 1MCKESSON CORPORATION2023 awards$11.98B
- 2BAVARIAN NORDIC A/S1 award$1.17B
- 3EMERGENT BIOSOLUTIONS CANADA INC2 awards$624.99M
- 4CHARTWELL RX LLC3 awards$254.44M
- 5ALVOGEN, INC.1 award$227.68M
- 6MERCK SHARP & DOHME LLC31 awards$157.47M
- 7GLAXOSMITHKLINE HOLDINGS (AMERICAS) INC.1 award$130.32M
- 8ELUSYS THERAPEUTICS INC1 award$124.52M
Drawn from official USAspending contract records in our index. Always confirm requirements on the SAM.gov notice before you bid.
Intelligence only — not legal advice or a guarantee of award. Always verify requirements on the official SAM.gov notice. Past award amounts are public history, not a suggested bid or prediction. Notice ID a89a6e6a15d348f98a72af085fae6da0.